Reducing radiation in chronic total occlusion percutaneous coronary interventions
Antonis N Pavlidis1, Daniel A Jones, Alex Sirker
1Department of Cardiology, London Chest Hospital, Barts Health NHS Trust, London, UK. antonispav@yahoo.com.
Current Cardiology Reviews
|April 8, 2015
Summary
Recent innovations in percutaneous intervention for chronic total occlusion (CTO) improve success rates and patient outcomes. However, complex procedures involve prolonged x-ray exposure, posing long-term risks.
Area of Science:
- Cardiovascular Interventions
- Interventional Cardiology
Background:
- Chronic total occlusion (CTO) percutaneous intervention has advanced significantly.
- Novel techniques and technologies have increased success rates in complex CTO cases.
Purpose of the Study:
- To review recent innovations in CTO percutaneous intervention.
- To highlight the clinical benefits and potential risks associated with these procedures.
Main Methods:
- Review of recent advancements in CTO percutaneous intervention techniques and technologies.
- Analysis of clinical outcomes and associated risks.
Main Results:
- Higher success rates achieved in complex CTO interventions.
- Significant clinical benefits including improved angina, quality of life, and reduced mortality.
- Prolonged x-ray exposure during complex procedures is linked to adverse long-term outcomes.
Conclusions:
- Percutaneous intervention for CTO offers substantial clinical benefits.
- Managing radiation exposure is crucial for mitigating long-term risks in complex CTO procedures.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
616
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
616
01:27Coronary Artery Disease V: Interprofessional Care
423
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
01:28Acute Coronary Syndrome IV: Interprofessional Care
493
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
493
01:26Angina IV: Management
441
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441